Records 1 - 12 (of 12 Records)
|Query Trace: Lung Neoplasms and AKT2[original query]|
| AKT1 and AKT2 mutations in lung cancer in a Japanese population.
Molecular medicine reports 0 1 (5): 663-6.
Sasaki Hidefumi, Okuda Katsuhiro, Kawano Osamu, Yukiue Haruhiro, Yano Motoki, Fujii Yoshita
| PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2011 Jan 71 (1): 82-8.
Pu Xia, Hildebrandt Michelle A T, Lu Charles, Lin Jie, Stewart David J, Ye Yuanqing, Gu Jian, Spitz Margaret R, Wu Xife
| MEK1 and AKT2 mutations in Japanese lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Mar .
Sasaki H, Hikosaka Y, Kawano O, Moriyama S, Yano M, Fujii Y
| MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013 May 8 (5): 574-81.
Boland Jennifer M, Jang Jin Sung, Li Jun, Lee Adam M, Wampfler Jason A, Erickson-Johnson Michele R, Soares Ibere, Yang Ping, Jen Jin, Oliveira Andre M, Yi Eunhee
| Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Nov 19 (22): 6252-60.
Li Qianxia, Yang Ju, Yu Qianqian, Wu Huanlei, Liu Bo, Xiong Huihua, Hu Guangyuan, Zhao Jing, Yuan Xianglin, Liao Zhongxi
| Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy.
Cancer medicine 2015 Dec .
Tang Yang, Liu Bo, Li Jing, Wu Huanlei, Yang Ju, Zhou Xiao, Yi Mingxiao, Li Qianxia, Yu Shiying, Yuan Xiangl
| Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung.
Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Aug .
Miyoshi Tomohiro, Umemura Shigeki, Matsumura Yuki, Mimaki Sachiyo, Tada Satoshi, Ishii Genichiro, Udagawa Hibiki, Matsumoto Shingo, Yoh Kiyotaka, Niho Seiji, Ohmatsu Hironobu, Aokage Keiju, Hishida Tomoyuki, Yoshida Junji, Nagai Kanji, Goto Koichi, Tsuboi Masahiro, Tsuchihara Katsu
| The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients.
Oncotarget 2016 Feb .
Wu Shang-Gin, Liu Yi-Nan, Tsai Meng-Feng, Chang Yih-Leong, Yu Chong-Jen, Yang Pan-Chyr, Yang James Chih-Hsin, Wen Yueh-Feng, Shih Jin-Yu
| Short-Term Responders of Non-Small Cell Lung Cancer Patients to EGFR Tyrosine Kinase Inhibitors Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms.
Translational oncology 2018 9 11 (6): 1364-1369.
Xu Yanjun, Tong Xiaoling, Yan Junrong, Wu Xue, Shao Yang W, Fan Y
| Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.
Genes, chromosomes & cancer 2018 Aug .
Wu Shang-Gin, Liu Yi-Nan, Yu Chong-Jen, Yang James Chih-Hsin, Shih Jin-Yu
| Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing.
Journal of thoracic disease 2021 Aug 13 (8): 5007-5015.
Zhang Fan, Wang Junyan, Ma Minting, Xu Yu, Lu Xiangjun, Wei Su
| Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer.
Advances in radiation oncology 0 6 (1): 100615.
Luo Leo Y, Samstein Robert M, Dick-Godfrey Rosalind, Sidiqi Baho, Wang Chunyu, Oro Federica, Sonnick Mark, Paik Paul K, Chaft Jamie E, Shaverdian Narek, Gomez Daniel R, Rimner Andreas, Wu Abraham